Cargando…
Stereotactic Body Radiation Therapy for Prostate Cancer: An Institutional Experience Using MRI-guided Treatment Planning
With 222,500 new cases estimated for 2017, prostate cancer makes up approximately 10% of all new cancer diagnoses in the United States and is the third most common cancer after breast and lung cancer. In 2013, the American Society of Radiation Oncology (ASTRO) policy model recognized that stereotact...
Autores principales: | Waheed, Nabila L, Yoder, Alison K, Van Wyhe, Renae D, Carpenter, Steven L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037339/ https://www.ncbi.nlm.nih.gov/pubmed/30009104 http://dx.doi.org/10.7759/cureus.2590 |
Ejemplares similares
-
Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer: A Promising Approach
por: Luterstein, Elaine, et al.
Publicado: (2018) -
The Association of Radiation Dose With Overall Survival for Patients Treated With Prostate Stereotactic Body Radiation Therapy
por: Waters, Michael R, et al.
Publicado: (2023) -
Real-time Magnetic Resonance-guided Liver Stereotactic Body Radiation Therapy: An Institutional Report Using a Magnetic Resonance-Linac System
por: Feldman, Aharon M, et al.
Publicado: (2019) -
Structure guided deformable image registration for treatment planning CT and post stereotactic body radiation therapy (SBRT) Primovist(®) (Gd‐EOB‐DTPA) enhanced MRI
por: Kuznetsova, Svetlana, et al.
Publicado: (2019) -
Impact of Age on Patient-Reported Outcomes Following Stereotactic Body Radiation Therapy for Prostate Cancer
por: Pepin, Abigail, et al.
Publicado: (2021)